Overview

A Clinical Study to Test Efficacy and Safety of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain

Status:
Active, not recruiting

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

This is a phase 3, randomized, double-blind, placebo-controlled, single injection, 52-week study to evaluate the efficacy and safety of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.

Phase:

Phase 3

Details

Lead Sponsor:

Centrexion Therapeutics

Treatments:

Capsaicin